内嵌镧金属富勒烯的高产率合成及异构体比例调控

采用电弧放电法制备内嵌镧金属富勒烯的原灰,通过改变氦气压力及电流强度来提高内嵌镧金属富勒烯产率。原灰由1,2,4-三氯苯提取并回溶入甲苯后,利用分析型高相液相色谱(HPLC)对提取液中各富勒烯组分进行分析。通过分别衡量3种常见含镧金属富勒烯La@C2v-C82、La@Cs-C82和La_2@C_(80)与C84的相对峰面积比,探讨了氦气压力和电流强度等对3种金属富勒烯产率的影响。实验结果表明,氦气压力与电流强度共同决定了金属富勒烯的产率,在(1)低电流高氦气压、(2)中等电流中等氦气压、(3)高电流低氦气压的条件下都可以高产率地获得含镧金属富勒烯。此外,调整电流强度和氦气压力可以改变La@C2v-C82和La@Cs-C82的相对比例。例如,在电流为100、120 A或氦气压为20、35 k Pa时,此前认为的"minor"异构体La@Cs-C82的含量甚至高于"major"异构体La@C2v-C82。还发现降低电流强度或减小氦气压力可促进La_2@C_(80)的生成,这表明La_2@C_(80)与La@C82的形成过程可能是不同的。     

茂金属催化剂催化1-癸烯齐聚研究

考察了1-癸烯和不同结构的茂金属催化剂((η5矿-C5 H5)2ZrCl2,A;[μ,μ-(Me2Si)2(η5-C5H3)2][(η5-C5H5)ZrCl2)]2,B;[(C6H5)C(Me)2(η5-C5H4)]2ZrCl2,C;tBuNC (Me)2(η5-C5H4)ZrCl2,D;(5-C5H4)C(C5H10)(η5-C13H8) ZrCl2,E;(η5-C5 H4)C(Me)2(η5-C13H8)ZrCl2,F;(η5-C5H4)C(C6H5)2(η5-C13 H8)ZrCl2,G)/MAO的齐聚反应,并探讨了茂金属F的用量,聚合温度和Al/Zr比对聚合反应和齐聚物性能的影响.实验结果表明,由于其不同的位阻效应和电子效应,不同结构的茂金属对1-癸烯的催化活性和齐聚物组分分布影响显著.其中,Cp2 ZrCl2,双核硅桥联的茂金属B和大位阻的茂金属C主要合成低粘度的齐聚物(100℃Kv:2～3 cSt,二聚体含量约为60％);限制构型的茂金属D因为有更加开放的配位结构呈现出高的催化活性,齐聚物的粘度也略高(100℃Kv:3 ～4 cSt);Cs-对称型茂金属E,F,G都有较高的催化活性,合成的齐聚物粘度也较高(100℃Kv＞20 cSt),主要归因于茂金属的特殊结构和聚合机理.GC-MS结果表明茂金属催化1-癸烯合成的齐聚物异构化较少,主要由二聚体到五聚体的混合物组成.茂金属F催化1-癸烯较优的齐聚条件是催化剂用量10 μmol,聚合温度80℃,Al/Zr比300∶1.     

Cp_2M_2(μ-B_4N_4H_8)(M=V,Cr,Mn,Fe)金属多重键成键性质的理论研究

对金属多重键配合物Cp2M2(μ-B4N4H8)(M=V,Cr,Mn,Fe)的结构和成键进行了理论研究,并与Cp2M2(μ-C8H8)进行对比.计算结果表明,在Cp2M2(μ-B4N4H8)基态构型中,B4N4H8配体均以硼为桥原子,金属原子的配位数均为5.其中,Cp2M2(μ-B4N4H8)(M=V,Cr,Mn)基态的结构和成键都与Cp2M2(μ-C8H8)非常接近;而Cp2Fe2(μ-B4N4H8)基态结构与Fe为4配位的Cp2Fe2(μ-C8H8)有所不同.Cp2M2(μ-B4N4H8)(M=V,Cr,Mn,Fe)基态结构分别为含V-V三重键的三态、含Cr-Cr三重键的单态、含Mn-Mn双键的三态及含Fe-Fe单键的单态.     

N-甲基吡咯-2-甲醛激发态结构动力学及其溶剂效应的共振拉曼光谱和密度泛函理论研究

获取了覆盖N-甲基吡咯-2-甲醛(NMPCA)A-带和B-带电子吸收共7个激发波长的共振拉曼光谱,并结合含时密度泛函理论(TD-DFT)方法研究了的A-带和B-带电子激发和Franck-Condon区域结构动力学.TD-B3LYP/6-311++G(d,p)计算表明:A-带和B-带电子吸收的跃迁主体为π→π*.共振拉曼光谱可以指认为,11-13振动模式(A-带激发)或者7-11振动模式(B-带激发)的基频、倍频和组合频,其中C=O伸缩振动(ν7)、环的变形振动+N1-C6伸缩振动(ν17)、环的变形振动(ν21)和C6-N1-C2/C2-C3-C4不对称伸缩振动(ν14)占据了绝大部分.这表明NMPCA的Sπ激发态结构动力学主要沿C=O伸缩振动、环的变形振动和环上N1-C6伸缩振动等反应坐标展开.在同一溶剂的共振拉曼光谱中随激发波长由长变短,ν7与ν14的强度比呈现出由强变弱再变强的现象,这种变化规律被认为与Franck-Condon区域Sn/Sπ态混合或势能面交叉有关.溶剂对Sn/Sπ态混合或势能面交叉具有调控作用.     

含吡咯基亚胺配体稀土铕配合物催化合成胍

以2-(2,4,6-Me3C6H2N=CH)C4H3NH为配体与铕配合物[(Me3Si)2N]3Eu(μ-Cl)Li(THF)3反应,合成了三价铕金属配合物[2-(2,4,6-Me3C6H2N=CH)C4H3N]3Eu(THF),以此配合物为催化剂催化芳胺与N,N’-二异丙基碳二亚胺反应,得到一系列胍产物,研究了反应时间、温度、催化剂用量和溶剂对催化反应的影响。结果表明:铕配合物具有良好的催化活性,以2%mol的催化剂用量、在THF中加热60℃反应8 h,得到高于80%产率的相应胍产物。     

m-4-m型Gemini表面活性剂对铂电极上亚甲蓝吸附溶出伏安行为的影响

在0.050 mol·L-1磷酸盐缓冲溶液(PBS)中(pH=6.4), 亚甲蓝(MB)在铂电极上于-0.2 V产生一对不明显的伏安峰. 当向溶液中加入阳离子型Gemini表面活性剂Br-C16H33N+(CH3)2-C4H8-N+(CH3)2C16H33Br-, Br-C12H25N+(CH3)2-C4H8-N+(CH3)2C12H25Br-或Br-C8H17N+(CH3)2-C4H8-N+(CH3)2C8H17Br-后, 亚甲蓝的氧化峰显著增高, 还原峰降低, 氧化还原峰峰电位均正移, 这和表面活性剂与MB在电极表面的协同吸附有关. 联接基团相同的Gemini表面活性剂, 其影响程度随烷基链的增长而逐渐增强. 增大表面活性剂的浓度, MB的氧化峰先升高后缓慢降低. 如当Br-C16H33N+(CH3)2-C4H8-N+(CH3)2C16H33Br-的浓度为15 μmol·L-1 时, 5 μmol·L-1 MB的氧化峰峰电流达到最大值. 此外,溶液pH值和富集电位等对MB及表面活性剂的吸附亦有影响.     

VMgO催化剂上丙烷和异丁烷临氧催化转化机理

用程序升温反应 -红外光谱技术研究 2 0VMgO和 6 0VMgO催化剂上丙烷和异丁烷临氧催化转化的机理 .结果表明 ,临氧条件下的反应性是异丁烷 >丙烷 ,与其分子中最弱C -H键键能从弱到强顺序相同 ,这意味着临氧活化的第一步可能是断裂分子中强度最弱的C -H键、且为速率控制步骤 ;丙烷临氧反应的深度氧化产物COx 与氧化脱氢产物丙烯的生成是平行和 (或 )连续反应关系 ,而裂解产物乙烯和甲烷的生成则是平行反应 ;异丁烷氧化脱氢反应中C -C键的断裂比丙烷的容易 .     

两个新型锌的配位聚合物的合成与晶体结构

本文以Zn(NO3)2.6H2O分别与1,3,5-均苯三甲酸(1,3,5-H3BTC)和2,5-噻吩二羧酸(2,5-H2TDC)通过水热/溶剂热反应合成了2个锌的配位聚合物[Zn3(OH)(BTC)2(C4N2H11)(H2O)]n(1)(C4N2H11=质子化的哌嗪)和[Zn(2,5-TDC)(i-PrOH)]n(2)。并对配位聚合物1和2进行了元素分析、FTIR和X-射线单晶结构解析等表征。X-射线单晶结构解析表明配位聚合物1和2的晶体均属于正交晶系,空间群分别为Pbca和P212121。化合物1中含有Zn3O结构单元,Zn3O结构单元通过BTC的连接构成1个层状结构,层状结构再通过堆积形成1个三维结构。化合物2中含有无机的Zn-O链。无机Zn-O链通过TDC配体与相邻的6个无机Zn-O链相连形成三维开放式的框架结构。     

配合物[RE_2(H_2L)_2(HL)_2(2,6-H_2PDA)(H_2O)_2]·2H_2O的合成、晶体结构及其与DNA作用方式初探

以N-(2-异丙酸)-邻羟基苯甲酰腙(C10H10N2O4,H3L)、2,6-吡啶二甲酸(2,6-H2PDA)与RE(NO3)3·nH2O(RE=Pr,Eu)在室温下反应,合成了配合物1[Pr2(H2L)2(HL)2(2,6-H2PDA)(H2O)2]·2H2O和配合物2[Eu2(H2L)2(HL)2(2,6-H2PDA)-(H2O)2]·2H2O,对其进行了元素分析、红外光谱、紫外光谱等表征,测定了两种配合物的晶体结构.通过紫外吸收光谱、荧光发射光谱和稳态荧光猝灭方法及其与溴化乙锭(EB)的竞争实验研究了两种配合物与小牛胸腺DNA的作用情况.结果表明,两种配合物与小牛胸腺DNA均是以插入方式结合的.     

2-乙酰基-1-甲基吡咯激发态结构动力学及溶剂效应的共振拉曼光谱和密度泛函理论计算

获取了覆盖紫外光谱中A带和B带吸收的共7个不同激发波长的共振拉曼光谱, 并结合密度泛函理论方法研究了2-乙酰基-1-甲基吡咯(2-Ac-NMP)的A带和B带电子激发和Franck-Condon区域结构动力学. 在TD-B3LYP/6-311++G(d,p)计算水平上, A带和B带吸收的跃迁主体为π→π^* . A带和B带共振拉曼光谱分别指认为13个振动模式和8个振动模式的基频、泛频和组合频, 其中C＝O伸缩振动(ν₈)、C3-C4-C5不对称伸缩振动+C2-C6伸缩振动(ν₁₄)及环上CH面内摇摆(ν₁₈)对拉曼光谱强度贡献最大, 表明2-Ac-NMP的S_π激发态结构动力学主要沿反应坐标展开. 考察了溶剂对共振拉曼光谱强度模式的影响, 结果表明, 在同一溶剂中, 随激发波长由长变短, C＝O伸缩振动模(ν₈)的强度呈现出由强变弱再变强的现象. 这种变化规律与Franck-Condon区域S_n/S_π态混合或势能面交叉相关, 并受溶剂的有效调控.     

Preparation and reactivity of mixed-ligand ruthenium(II) hydride complexes with phosphites and polypyridyls

Chloro complexes [RuCl(N-N)P3]BPh4 (1-3) [N-N = 2,2'-bipyridine, bpy; 1,10-phenanthroline, phen; 5,5'-dimethyl-2,2'-bipyridine, 5,5'-Me2bpy; P = P(OEt)3, PPh(OEt)2 and PPh2OEt] were prepared by allowing the [RuCl4(N-N)].H2O compounds to react with an excess of phosphite in ethanol. The bis(bipyridine) [RuCl(bpy)2[P(OEt)3]]BPh4 (7) complex was also prepared by reacting RuCl2(bpy)2.2H2O with phosphite and ethanol. Treatment of the chloro complexes 1-3 and 7 with NaBH4 yielded the hydride [RuH(N-N)P3]BPh4 (4-6) and [RuH(bpy)2P]BPh4 (8) derivatives, which were characterized spectroscopically and by the X-ray crystal structure determination of [RuH(bpy)[P(OEt)3]3]BPh4 (4a). Protonation reaction of the new hydrides with Br?nsted acid was studied and led to dicationic [Ru(eta2-H2)(N-N)P3]2+ (9, 10) and [Ru(eta(2-H2)(bpy)2P]2+ (11) dihydrogen derivatives. The presence of the eta2-H2 ligand was indicated by a short T(1 min) value and by the measurements of the J(HD) in the [Ru](eta2-HD) isotopomers. From T(1 min) and J(HD) values the H-H distances of the dihydrogen complexes were also calculated. A series of ruthenium complexes, [RuL(N-N)P3](BPh4)2 and [RuL(bpy)2P](BPh4)2 (P = P(OEt)3; L = H2O, CO, 4-CH3C6H4NC, CH3CN, 4-CH3C6H4CN, PPh(OEt)2], was prepared by substituting the labile eta2-H2 ligand in the 9, 10, 11 derivatives. The reactions of the new hydrides 4-6 and 8 with both mono- and bis(aryldiazonium) cations were studied and led to aryldiazene [Ru(C6H5N=NH)(N-N)P3](BPh4)2 (19, 21), [[Ru(N-N)P3]2(mu-4,4'-NH=NC6H4-C6H4N=NH)](BPh4)4 (20), and [Ru(C6H5N=NH)(bpy)2P](BPh4)2 (22) derivatives. Also the heteroallenes CO2 and CS2 reacted with [RuH(bpy)2P]BPh4, yielding the formato [Ru[eta1-OC(H)=O](bpy)2P]BPh4 and dithioformato [Ru[eta1-SC(H)=S](bpy)2P]BPh4 derivatives.     

C4H8N2H4·Zn(HPO3)2的水热合成和结构表征

在过去的十几年中 ,人们对含有机模板的、由 Zn O4 四面体和 PO4 四面体基本结构单元组成的磷酸锌盐进行了深入广泛的研究 ,发现其结构具有多样性 [1] .近年来 ,人们又开始探索用亚磷酸氢根( HPO3)替代磷酸根 ( PO4 ) ,形成结构新颖的含有机模板的亚磷酸盐 .与磷酸根相比 ,亚磷酸氢根只能与 3个邻近的阳离子通过 P— O— M( M=Zn等 )键相连 ,结构同 [PO3( OH) ]相似 .鉴于此 ,HPO3完全可以作为搭建空旷骨架化合物的结构基元 .与磷酸盐的研究相比 ,以有机胺为模板的过渡金属亚磷酸盐合成研究相对较少 .Harrison等 [2 ,3] 报道了通过…     

水溶性金属勒烯衍生物的合成和表征

金属富勒烯具有表面积大(2 nm2)、整体电中性、金属离子的解离常数Kd为0等独特的性质, 在医学上具有重要的应用价值[1～7]. 要将其用于生物体系, 需引入亲水基团. 水溶性Gd@C82(OH)x已被证实是一种比临床上应用的GdDTPA更好的核磁成像造影剂(其弛豫率比GdDTPA高20倍[7]), 并有望用作放射性示踪剂和放射性药物等, 且在生物体内外具有稳定性[2～6], 是生物医学上很有吸引力的材料. 本文在高效合成、分离纯化 Gd@C82的基础上合成了其多羟基衍生物、多取代氨基酸衍生物和多取代氨基磺酸衍生物, 并作了初步分析.     

Hydrogen-bonding directed cocrystallization of flexible piperazine with hydroxybenzoic acid derivatives: Structural diversity and synthon prediction

Four hydroxybenzoic acid building blocks,m-hydroxybenzoic acid,2,4-dihydroxybenzoic acid,2,5-dihydroxyterephthalic acid,and 5-hydroxyisophthalic acid,have been synthesized as robust cocrystallizing agents and employed in reactions with piperazine,including [(C4H12N22+).(C7H5O3)2 ](1),[(C4H12N22+).(C 7H5O4)2 ](2),[(C4H12N22+).(C8H5O62)](3),and [(C4H12N22+)1/2.(C8H5O5)].2H2O(4).Hydrogen-bonded directed assemblies of four salts were validated by single-crystal X-ray diffraction analysis.In compounds 1-4,hydroxybenzoic acids are all deprotonated and piperazine molecules are all protonated to form piperazine dications and keep the chair conformation.Thermal stability of these compounds has been investigated.     

Scandium and yttrium metallocene borohydride complexes: comparisons of (BH4)1- vs. (BPh4)1- coordination and reactivity

The synthetically accessible borohydride complexes (C(5)Me(4)H)(2)Ln(THF)(BH(4)) and (C(5)Me(5))(2)Ln(THF)(BH(4)) (Ln = Sc, Y) were examined as precursors alternative to the heavily-used tetraphenylborate analogs, [(C(5)Me(4)H)(2)Ln][BPh(4)] and [(C(5)Me(5))(2)Ln][BPh(4)], employed in LnA(2)A'/M reduction reactions (A = anion; M = alkali metal) that generate "LnA(2)" reactivity and form reduced dinitrogen complexes [(C(5)R(5))(2)(THF)(x)Ln](2)(μ-η(2):η(2)-N(2)) (x = 0, 1). The crystal structures of the yttrium borohydrides, (C(5)Me(4)H)(2)Y(THF)(μ-H)(3)BH, 1, and (C(5)Me(5))(2)Y(THF)(μ-H)(2)BH(2), 2, were determined for comparison with those of the yttrium tetraphenylborates, [(C(5)Me(4)H)(2)Y][(μ-Ph)(2)BPh(2)], 3, and [(C(5)Me(5))(2)Y][(μ-Ph)(2)BPh(2)], 4. The complex (C(5)Me(4)H)(2)Sc(μ-H)(2)BH(2), 5, was synthesized and structurally characterized for comparison with (C(5)Me(5))(2)Sc(μ-H)(2)BH(2), 6, [(C(5)Me(4)H)(2)Sc][(μ-Ph)BPh(3)], 7, and [(C(5)Me(5))(2)Sc][(μ-Ph)BPh(3)], 8. Structural information was also obtained on the borohydride derivatives, (C(5)Me(4)H)(2)Sc(μ-H)(2)BC(8)H(14), 9, and (C(5)Me(5))(2)Sc(μ-H)(2)BC(8)H(14), 10, obtained from 9-borabicyclo(3.3.1)nonane (9-BBN) and (C(5)Me(4)R)(2)Sc(η(3)-C(3)H(5)), where R = H, 11; Me, 12. The preference of the metals for borohydride over tetraphenylborate binding was shown by the facile displacement of (BPh(4))(1-) in 3, 4, 7, and 8 by (BH(4))(1-) to make the respective borohydride complexes 1, 2, 5, and 6. These results are consistent with the fact that the borohydrides are not as useful as precursors in A(2)LnA'/M reductions of N(2). An unusual structural isomer of [(C(5)Me(4)H)(2)Sc](2)(μ-η(2):η(2)-N(2)), 13', was isolated from this study that shows the variations in ligand orientation that can occur in the solid state.     

Synthesis and Crystal Structure of 3-（4-Chlorophenyl）-8-cyano-2-（di-isopropylamino）-5-methyl-7-（methylthio）-pyrido[4,3-d]pyrimidine-4（3H）-one

The crystal structure of the new title compound 3-(4-chlorophenyl)-8-cyano-2-(di-iso-propylamino)-5-methyl-7-(methylthio)-pyrido[4,3-d]pyrimidine-4(3H)-one(C22H24ClN5OS,Mr = 441.97)has been determined by single-crystal X-ray diffraction. The crystal is of orthorhombic,space group Pna21 with a = 7.6721(5),b = 18.9370(11),c = 15.6260(9),V = 2270.2(2)3,Z = 4,Dc = 1.293 g/cm3,F(000)= 928,μ = 0.283 mm-1,MoKa radiation(λ = 0.71073 ),R = 0.0494 and wR = 0.1062 for 3278 observed reflections with I > 2σ(I). X-ray diffraction analysis reveals that all ring atoms in the py-ridopyrimidinone moiety are almost coplanar. Intramolecular C(20)-H(20)···N(4),C(19)-H(19A)···N(3),C(18)-H(18C)···N(3)and C(16)-H(16B)···O(5)hydrogen bonds together with weak C···π interactions are found in the structure.     

Unprecedented head-to-head conformers of d(GpG) bound to the antitumor active compound tetrakis (mu-carboxylato)dirhodium(II,II)

The N7/O6 equatorial binding interactions of the antitumor active complex Rh(2)(OAc)(4)(H(2)O)(2) (OAc(-) = CH(3)CO(2)(-)) with the DNA fragment d(GpG) have been unambiguously determined by NMR spectroscopy. Previous X-ray crystallographic determinations of the head-to-head (HH) and head-to-tail (HT) adducts of dirhodium tetraacetate with 9-ethylguanine (9-EtGH) revealed unprecedented bridging N7/O6 guanine nucleobases that span the Rh-Rh bond. The absence of N7 protonation at low pH and the notable increase in the acidity of N1-H (pK(a) approximately 5.7 as compared to 8.5 for N7 only bound platinum adducts), suggested by the pH dependence titrations of the purine H8 (1)H NMR resonances for Rh(2)(OAc)(2)(9-EtG)(2) and Rh(2)(OAc)(2-)[d(GpG)],are consistent with bidentate N7/O6 binding of the guanine nucleobases. The pK(a) values estimated for N1-H (de)protonation, from the pH dependence studies of the C6 and C2 (13)C NMR resonances for the Rh(2)(OAc)(2)(9-EtG)(2) isomers, concur with those derived from the H8 (1)H NMR resonance titrations. Comparison of the (13)C NMR resonances of C6 and C2 for the dirhodium adducts Rh(2)(OAc)(2)(9-EtG)(2) and Rh(2)(OAc)(2)[d(GpG)] with the corresponding resonances of the unbound ligands [at pH 7.0 for 9-EtGH and pH 8.0 for d(GpG)], shows substantial downfield shifts of Deltadelta approximately 11.0 and 6.0 ppm for C6 and C2, respectively; the latter shifts reflect the effect of O6 binding to the dirhodium centers and the ensuing enhancement in the acidity of N1-H. Intense H8/H8 ROE cross-peaks in the 2D ROESY NMR spectrum of Rh(2)(OAc)(2)[d(GpG)] indicate head-to-head arrangement of the guanine bases. The Rh(2)(OAc)(2)[d(GpG)] adduct exhibits two major right-handed conformers, HH1 R and HH2 R, with HH1 R being three times more abundant than the unusual HH2 R. Complete characterization of both adducts revealed repuckering of the 5'-G sugar rings to C3'-endo (N-type), retention of C2'-endo (S-type) conformation for the 3'-G sugar rings, and anti orientation with respect to the glycosyl bonds. The structural features obtained for Rh(2)(OAc)(2))[d(GpG)] by means of NMR spectroscopy are very similar to those for cis-[Pt(NH(3))(2))[d(GpG)]] and corroborate molecular modeling studies.     

新型三维开放骨架稀土硫酸盐[Ln4(H2O)4(SO4)10](C4N2H12)4(H2O)4(Ln=Gd,Eu)的合成、结构及荧光性质

以哌嗪为模板剂,在水-乙醇混合溶剂体系中溶剂热合成了两个具有三维开放骨架结构的稀土硫酸盐[Ln4(H2O)4(SO4)10](C4N2H12)4(H2O)4（Ln = Gd,化合物1和Eu,化合物2）,并对其进行了结构表征、热重以及荧光光谱分析. 单晶结构解析表明,化合物1和2属于同构异质,均结晶于单斜晶系,P21/c空间群,化合物1,a = 19.691(3) ?,b = 19.249(3) ?,c = 13.186(2) ?,β = 92.33(0)o,V = 4993.5(1) ?3, Z =4. 化合物2,a = 19.7233(8) ?,b = 19.2791(8) ?,c = 13.2095(5) ?,β = 92.329(1)o,V = 5018.7(3) ?3, Z =4. 两个化合物在ab平面上由SO4,GdO8和GdO9多面体共边或共角交错连接形成含有八元环和十六元环的二维层状结构,该二维层沿c方向平行排列,相邻层通过SO4四面体相连形成具有孔道的三维开放骨架结构,其孔道之中包含平衡骨架负电荷的质子化哌嗪分子. 化合物2的固体荧光光谱分析显示其在397nm激发波长下,表现出典型的Eu3+发光性质.       

Synthesis,characterization, X-ray diffraction studies and biological evaluation of tert-butyl 4-(2-ethoxy-2-oxoethyl)-piperazine-1-carboxylate and tert-butyl 4-(2-hydrazino-2-oxoethyl)piperazine-1-carboxylate

Two derivatives of N-Boc piperazine, an ester derivative, i.e., tert-butyl 4-(2-ethoxy-2-oxoethyl)-piperazine-1-carboxylate (1), and, a hydrazide derivative tert-butyl 4-(2-hydrazino-2-oxoethyl)piperazine-1-carboxylate (2) were synthesized and were characterized by FT-IR, ¹H & ¹³C NMR and LCMS spectroscopic studies. The structures of both 1 and 2 were further confirmed by single crystal X-ray diffraction analysis. The molecule of 1 is linear in shape with the ethyl acetate moiety adopting fully extended conformation, while the molecule of 2 is L-shaped with the molecule being twisted at the C10 atom. The crystal structure of 1 adopts a two-dimensional zig-zag architecture featuring C–H…O intermolecular interactions, while that of 2 features strong N–H…O hydrogen bonds and intermolecular interactions of the type N–H…N and C–H…N, resulting in a two-dimensional structure. Furthermore, a detailed analysis of the intermolecular interactions and crystal packing of 1 and 2 via Hirshfeld surface analysis and fingerprint plots was performed. The antibacterial and antifungal activities of both the compounds have been studied against several microorganisms, and were found to be moderately active.